Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor GluR3

Neurology

Volumn 46, Issue 1, 1996, Pages 247-249

  Krauss, G L ^a,b   Campbell, M L ^a   Roche, K W ^a   Huganir, R L ^a   Niedermeyer, E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; GLUTAMATE RECEPTOR; IMMUNOGLOBULIN; MESNA; METHYLPREDNISOLONE; ONDANSETRON; PREDNISONE; RECEPTOR ANTIBODY; STEROID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; ENCEPHALITIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030004362     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.1.247     Document Type: Article

References (10)

1. Aguilar MJ, Rasmussen T. Role of encephalitis in pathogenesis of epilepsy. Arch Neurol 1960;2:663-676.
2. Vining EPG, Freeman JM, Brandt J, Carson BS, Uematsu S. Progressive unilateral encephalopathy of childhood (Rasmussen's syndrome): a reappraisal. Epilepsia 1993;34:639-650.
3. Hart L, Cortez M, Andermann NF, et al. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology 1994;44:1030-1036.
4. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648-651.
5. Andrews PI, Rogers SW, Gahring LC, et al. Glutamate receptor GluR3 is an autoantigen in Rasmussen's encephalitis (RE) [abstract]. Epilepsia 1994;35(suppl 8):90.
6. Boumpas DT, Austin HA III, Vaughn EM, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992;340: 741-745.
7. DeToledo JC, Smith DB. Partially successful treatment of Rasmussen's encephalitis with zidovudine: symptomatic improvement followed by involvement of the contralateral hemisphere. Epilepsy 1994;35:352-355.
8. Cash JM, Klippel JH. Second-line drug therapy for rheumatoid arthritis. N Engl J Med 1994;1368-1375.
9. Austin HA III, Klippel JH, Balow JE, et al. Therapy of lupus nephritis-controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986;314:614-619.
10. Boumpas DT, Austin HA III, Vaughn EM, Yarboro CH, Klippel JH, Balow JE. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 1993;119: 366-369.